These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6888085)
1. Sorbent therapy of the porphyrias. II. Experimental plasma or hemoperfusion with a commercial charcoal cartridge. Tishler PV; Gordon BJ Methods Find Exp Clin Pharmacol; 1983; 5(3):185-91. PubMed ID: 6888085 [TBL] [Abstract][Full Text] [Related]
2. Sorbent therapy of the porphyrias. III. Comparative efficacy of experimental plasma perfusion with several commercial hemoperfusion cartridges. Tishler PV; Winston SH Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):389-93. PubMed ID: 6503474 [TBL] [Abstract][Full Text] [Related]
3. Sorbent therapy of the porphyrias. V. Adsorption of the porphyrin precursors delta-aminolevulinic acid and porphobilinogen by sorbents in vitro. Winston SH; Tishler PV Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):233-7. PubMed ID: 3724299 [TBL] [Abstract][Full Text] [Related]
4. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943 [TBL] [Abstract][Full Text] [Related]
7. Sorbent therapy of the porphyrias. IV. Adsorption of porphyrins by sorbents in vitro. Tishler PV; Winston SH Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):485-91. PubMed ID: 4079600 [TBL] [Abstract][Full Text] [Related]
9. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Sardh E; Harper P; Andersson DE; Floderus Y Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of glycerol and dextrose on porphyrin precursor excretion in acute intermittent porphyria. Bonkowsky HL; Magnussen CR; Collins AR; Doherty JM; Hess RA; Tschudy DP Metabolism; 1976 Apr; 25(4):405-14. PubMed ID: 1263834 [TBL] [Abstract][Full Text] [Related]
11. A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen. Zhang J; Yasuda M; Desnick RJ; Balwani M; Bishop D; Yu C J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2389-96. PubMed ID: 21783436 [TBL] [Abstract][Full Text] [Related]
12. Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes. Sardh E; Andersson DE; Henrichson A; Harper P Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):66-71. PubMed ID: 19268004 [TBL] [Abstract][Full Text] [Related]
13. Prophyrin precursors in blood, urine and cerebrospinal fluid in acute porphyria. Percy VA; Shanley BC S Afr Med J; 1977 Jul; 52(6):219-22. PubMed ID: 897913 [TBL] [Abstract][Full Text] [Related]
14. Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms. Mustajoki P; Timonen K; Gorchein A; Seppäläinen AM; Matikainen E; Tenhunen R Eur J Clin Invest; 1992 Jun; 22(6):407-11. PubMed ID: 1633836 [TBL] [Abstract][Full Text] [Related]
15. Charcoal haemoperfusion and haemodialysis in acute intermittent porphyria. Laiwah AC; Junor B; MacPhee GJ; Thompson GG; McColl KE Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1746-7. PubMed ID: 6416574 [TBL] [Abstract][Full Text] [Related]
16. Mass transfer characteristics of hollow-fiber dialyzers and hemoperfusion devices. Cooney DO; Daly JS Artif Organs; 1979 Aug; 3(3):253-7. PubMed ID: 533416 [TBL] [Abstract][Full Text] [Related]
17. [Acute intermittent porphyria in pregnancy: glucose or hematin therapy?]. Isenschmid M; König C; Fässli C; Haenel A; Hänggi W; Schneider H Schweiz Med Wochenschr; 1992 Nov; 122(46):1741-5. PubMed ID: 1448679 [TBL] [Abstract][Full Text] [Related]
18. Digoxin acute intoxication: evaluation of the efficiency of charcoal hemoperfusion. Clerckx-Braun F; Kadima N; Lesne M; Mahieu P; Vandenbroucke JM Clin Toxicol; 1979; 15(4):437-46. PubMed ID: 540492 [TBL] [Abstract][Full Text] [Related]
19. Biological evaluation of hemoperfusion in acute poisoning. Bismuth C; Fournier PE Dev Toxicol Environ Sci; 1980; 8():377-85. PubMed ID: 7308035 [TBL] [Abstract][Full Text] [Related]
20. Assessment of barbiturate removal by charcoal hemoperfusion in overdose cases. Iversen BM; Willassen Y; Bakke OM; Wallem G Clin Toxicol; 1979; 15(2):139-49. PubMed ID: 509879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]